<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 21 Sep 2026 08:30:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>BioMark Announces Participation in upcoming MSACL 2026 and BIOHorizon 2026 Life Sciences Conferences</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Announces+Participation+in+upcoming+MSACL+2026+and+BIOHorizon+2026+Life+Sciences+Conferences/27083393.html</link>
   <description>&lt;p&gt;The Company will provide an update on the clinical translation of its biomarker platform and showcase industry collaborations supporting scalable, high-throughput mass spectrometry.&lt;/p&gt;&lt;p&gt;Vancouver, British Columbia--(Newsfile Corp. - September 21, 2026) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) (&quot;BioMark&quot; or the &quot;Company&quot;), a leading developer of liquid biopsy technologies focused on the early detection of lung cancer through metabolomics, is pleased to announce today its participation in two upcoming life sciences events in Quebec during the week of October 4, 2026.&lt;/p&gt;&lt;p&gt;The Company will participate in the 16th Annual Mass Spectrometry &amp;#38; Advances in the Clinical Lab (MSACL 2026)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Announces+Participation+in+upcoming+MSACL+2026+and+BIOHorizon+2026+Life+Sciences+Conferences/27083393.html</guid>
   <pubDate>Mon, 21 Sep 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Announces Participation in upcoming MSACL 2026 and BIOHorizon 2026 Life Sciences Conferences</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Announces+Participation+in+upcoming+MSACL+2026+and+BIOHorizon+2026+Life+Sciences+Conferences/27083393.html</link>
   <description>&lt;p&gt;The Company will provide an update on the clinical translation of its biomarker platform and showcase industry collaborations supporting scalable, high-throughput mass spectrometry.&lt;/p&gt;&lt;p&gt;Vancouver, British Columbia--(Newsfile Corp. - September 21, 2026) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) (&quot;BioMark&quot; or the &quot;Company&quot;), a leading developer of liquid biopsy technologies focused on the early detection of lung cancer through metabolomics, is pleased to announce today its participation in two upcoming life sciences events in Quebec during the week of October 4, 2026.&lt;/p&gt;&lt;p&gt;The Company will participate in the 16th Annual Mass Spectrometry &amp;#38; Advances in the Clinical Lab (MSACL 2026)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Announces+Participation+in+upcoming+MSACL+2026+and+BIOHorizon+2026+Life+Sciences+Conferences/27083393.html</guid>
   <pubDate>Mon, 21 Sep 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Announces Participation in upcoming MSACL 2026 and BIOHorizon 2026 Life Sciences Conferences</title>
   <link>http://www.streetinsider.com/Newsfile/BioMark+Announces+Participation+in+upcoming+MSACL+2026+and+BIOHorizon+2026+Life+Sciences+Conferences/27083393.html</link>
   <description>&lt;p&gt;The Company will provide an update on the clinical translation of its biomarker platform and showcase industry collaborations supporting scalable, high-throughput mass spectrometry.&lt;/p&gt;&lt;p&gt;Vancouver, British Columbia--(Newsfile Corp. - September 21, 2026) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) (&quot;BioMark&quot; or the &quot;Company&quot;), a leading developer of liquid biopsy technologies focused on the early detection of lung cancer through metabolomics, is pleased to announce today its participation in two upcoming life sciences events in Quebec during the week of October 4, 2026.&lt;/p&gt;&lt;p&gt;The Company will participate in the 16th Annual Mass Spectrometry &amp;#38; Advances in the Clinical Lab (MSACL 2026)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Newsfile/BioMark+Announces+Participation+in+upcoming+MSACL+2026+and+BIOHorizon+2026+Life+Sciences+Conferences/27083393.html</guid>
   <pubDate>Mon, 21 Sep 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Announces Participation in upcoming MSACL 2026 and BIOHorizon 2026 Life Sciences Conferences</title>
   <link>http://www.streetinsider.com/Newsfile/BioMark+Announces+Participation+in+upcoming+MSACL+2026+and+BIOHorizon+2026+Life+Sciences+Conferences/27083393.html</link>
   <description>&lt;p&gt;The Company will provide an update on the clinical translation of its biomarker platform and showcase industry collaborations supporting scalable, high-throughput mass spectrometry.&lt;/p&gt;&lt;p&gt;Vancouver, British Columbia--(Newsfile Corp. - September 21, 2026) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) (&quot;BioMark&quot; or the &quot;Company&quot;), a leading developer of liquid biopsy technologies focused on the early detection of lung cancer through metabolomics, is pleased to announce today its participation in two upcoming life sciences events in Quebec during the week of October 4, 2026.&lt;/p&gt;&lt;p&gt;The Company will participate in the 16th Annual Mass Spectrometry &amp;#38; Advances in the Clinical Lab (MSACL 2026)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Newsfile/BioMark+Announces+Participation+in+upcoming+MSACL+2026+and+BIOHorizon+2026+Life+Sciences+Conferences/27083393.html</guid>
   <pubDate>Mon, 21 Sep 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>Form  D          Biomark Diagnostics Inc.             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Biomark+Diagnostics+Inc.+++++++++++++/24635578.html</link>
   <description>si-local-file:///var/storage/secattach/20250414/24635578.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Biomark+Diagnostics+Inc.+++++++++++++/24635578.html</guid>
   <pubDate>Mon, 14 Apr 2025 13:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22482725</category>
   	  </item>
  <item>
   <title>Form  D          Biomark Diagnostics Inc.             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Biomark+Diagnostics+Inc.+++++++++++++/24635578.html</link>
   <description>si-local-file:///var/storage/secattach/20250414/24635578.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Biomark+Diagnostics+Inc.+++++++++++++/24635578.html</guid>
   <pubDate>Mon, 14 Apr 2025 13:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22482725</category>
   	  </item>
  <item>
   <title>Form  D          Biomark Diagnostics Inc.             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Biomark+Diagnostics+Inc.+++++++++++++/24635578.html</link>
   <description>si-local-file:///var/storage/secattach/20250414/24635578.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Biomark+Diagnostics+Inc.+++++++++++++/24635578.html</guid>
   <pubDate>Mon, 14 Apr 2025 13:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22482725</category>
   	  </item>
  <item>
   <title>BioMark Completes Data Collection and Submits Data for Analysis Prior to Health Canada Submission</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Completes+Data+Collection+and+Submits+Data+for+Analysis+Prior+to+Health+Canada+Submission/11798953.html</link>
   <description>si-local-file:///var/storage/newsbody/2016/0705/11798953.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Completes+Data+Collection+and+Submits+Data+for+Analysis+Prior+to+Health+Canada+Submission/11798953.html</guid>
   <pubDate>Tue, 05 Jul 2016 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">20B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Completes Data Collection and Submits Data for Analysis Prior to Health Canada Submission</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Completes+Data+Collection+and+Submits+Data+for+Analysis+Prior+to+Health+Canada+Submission/11798953.html</link>
   <description>si-local-file:///var/storage/newsbody/2016/0705/11798953.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Completes+Data+Collection+and+Submits+Data+for+Analysis+Prior+to+Health+Canada+Submission/11798953.html</guid>
   <pubDate>Tue, 05 Jul 2016 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">20B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Completes Data Collection and Submits Data for Analysis Prior to Health Canada Submission</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Completes+Data+Collection+and+Submits+Data+for+Analysis+Prior+to+Health+Canada+Submission/11798953.html</link>
   <description>si-local-file:///var/storage/newsbody/2016/0705/11798953.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Completes+Data+Collection+and+Submits+Data+for+Analysis+Prior+to+Health+Canada+Submission/11798953.html</guid>
   <pubDate>Tue, 05 Jul 2016 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">20B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Completes Data Collection and Submits Data for Analysis Prior to Health Canada Submission</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Completes+Data+Collection+and+Submits+Data+for+Analysis+Prior+to+Health+Canada+Submission/11798953.html</link>
   <description>si-local-file:///var/storage/newsbody/2016/0705/11798953.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Completes+Data+Collection+and+Submits+Data+for+Analysis+Prior+to+Health+Canada+Submission/11798953.html</guid>
   <pubDate>Tue, 05 Jul 2016 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">20B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Completes Data Collection and Submits Data for Analysis Prior to Health Canada Submission</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Completes+Data+Collection+and+Submits+Data+for+Analysis+Prior+to+Health+Canada+Submission/11798953.html</link>
   <description>si-local-file:///var/storage/newsbody/2016/0705/11798953.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Completes+Data+Collection+and+Submits+Data+for+Analysis+Prior+to+Health+Canada+Submission/11798953.html</guid>
   <pubDate>Tue, 05 Jul 2016 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">20B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Diagnostics to Conduct Validation Studies for Its Patented Assays in Patients With Lung Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Conduct+Validation+Studies+for+Its+Patented+Assays+in+Patients+With+Lung+Cancer/10880863.html</link>
   <description>si-local-file:///var/storage/newsbody/2015/0910/10880863.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Conduct+Validation+Studies+for+Its+Patented+Assays+in+Patients+With+Lung+Cancer/10880863.html</guid>
   <pubDate>Thu, 10 Sep 2015 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.26262063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Diagnostics to Conduct Validation Studies for Its Patented Assays in Patients With Lung Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Conduct+Validation+Studies+for+Its+Patented+Assays+in+Patients+With+Lung+Cancer/10880863.html</link>
   <description>si-local-file:///var/storage/newsbody/2015/0910/10880863.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Conduct+Validation+Studies+for+Its+Patented+Assays+in+Patients+With+Lung+Cancer/10880863.html</guid>
   <pubDate>Thu, 10 Sep 2015 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.26262063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Diagnostics to Conduct Validation Studies for Its Patented Assays in Patients With Lung Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Conduct+Validation+Studies+for+Its+Patented+Assays+in+Patients+With+Lung+Cancer/10880863.html</link>
   <description>si-local-file:///var/storage/newsbody/2015/0910/10880863.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Conduct+Validation+Studies+for+Its+Patented+Assays+in+Patients+With+Lung+Cancer/10880863.html</guid>
   <pubDate>Thu, 10 Sep 2015 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.26262063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Diagnostics Receives Clearance From Health Canada to Commence Clinical Trial With Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+Receives+Clearance+From+Health+Canada+to+Commence+Clinical+Trial+With+Patented+Non-Invasive%2C+Urine-Based+Assay+to+Measure+Response+to+Treatment+for+Lung+Cancer/10876465.html</link>
   <description>si-local-file:///var/storage/newsbody/2015/0909/10876465.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+Receives+Clearance+From+Health+Canada+to+Commence+Clinical+Trial+With+Patented+Non-Invasive%2C+Urine-Based+Assay+to+Measure+Response+to+Treatment+for+Lung+Cancer/10876465.html</guid>
   <pubDate>Wed, 09 Sep 2015 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">20B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26262063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Diagnostics Receives Clearance From Health Canada to Commence Clinical Trial With Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+Receives+Clearance+From+Health+Canada+to+Commence+Clinical+Trial+With+Patented+Non-Invasive%2C+Urine-Based+Assay+to+Measure+Response+to+Treatment+for+Lung+Cancer/10876465.html</link>
   <description>si-local-file:///var/storage/newsbody/2015/0909/10876465.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+Receives+Clearance+From+Health+Canada+to+Commence+Clinical+Trial+With+Patented+Non-Invasive%2C+Urine-Based+Assay+to+Measure+Response+to+Treatment+for+Lung+Cancer/10876465.html</guid>
   <pubDate>Wed, 09 Sep 2015 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">20B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26262063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Diagnostics Receives Clearance From Health Canada to Commence Clinical Trial With Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+Receives+Clearance+From+Health+Canada+to+Commence+Clinical+Trial+With+Patented+Non-Invasive%2C+Urine-Based+Assay+to+Measure+Response+to+Treatment+for+Lung+Cancer/10876465.html</link>
   <description>si-local-file:///var/storage/newsbody/2015/0909/10876465.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+Receives+Clearance+From+Health+Canada+to+Commence+Clinical+Trial+With+Patented+Non-Invasive%2C+Urine-Based+Assay+to+Measure+Response+to+Treatment+for+Lung+Cancer/10876465.html</guid>
   <pubDate>Wed, 09 Sep 2015 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">20B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26262063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Diagnostics Receives Clearance From Health Canada to Commence Clinical Trial With Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+Receives+Clearance+From+Health+Canada+to+Commence+Clinical+Trial+With+Patented+Non-Invasive%2C+Urine-Based+Assay+to+Measure+Response+to+Treatment+for+Lung+Cancer/10876465.html</link>
   <description>si-local-file:///var/storage/newsbody/2015/0909/10876465.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+Receives+Clearance+From+Health+Canada+to+Commence+Clinical+Trial+With+Patented+Non-Invasive%2C+Urine-Based+Assay+to+Measure+Response+to+Treatment+for+Lung+Cancer/10876465.html</guid>
   <pubDate>Wed, 09 Sep 2015 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">20B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26262063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Diagnostics Receives Clearance From Health Canada to Commence Clinical Trial With Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+Receives+Clearance+From+Health+Canada+to+Commence+Clinical+Trial+With+Patented+Non-Invasive%2C+Urine-Based+Assay+to+Measure+Response+to+Treatment+for+Lung+Cancer/10876465.html</link>
   <description>si-local-file:///var/storage/newsbody/2015/0909/10876465.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+Receives+Clearance+From+Health+Canada+to+Commence+Clinical+Trial+With+Patented+Non-Invasive%2C+Urine-Based+Assay+to+Measure+Response+to+Treatment+for+Lung+Cancer/10876465.html</guid>
   <pubDate>Wed, 09 Sep 2015 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">20B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26262063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Diagnostics to Present at Rodman &amp;amp; Renshaw Global Investment Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Present+at+Rodman+%26amp%3B+Renshaw+Global+Investment+Conference/10865626.html</link>
   <description>si-local-file:///var/storage/newsbody/2015/0903/10865626.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Present+at+Rodman+%26amp%3B+Renshaw+Global+Investment+Conference/10865626.html</guid>
   <pubDate>Thu, 03 Sep 2015 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">20B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Diagnostics to Present at Rodman &amp;amp; Renshaw Global Investment Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Present+at+Rodman+%26amp%3B+Renshaw+Global+Investment+Conference/10865626.html</link>
   <description>si-local-file:///var/storage/newsbody/2015/0903/10865626.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Present+at+Rodman+%26amp%3B+Renshaw+Global+Investment+Conference/10865626.html</guid>
   <pubDate>Thu, 03 Sep 2015 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">20B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Diagnostics to Present at Rodman &amp;amp; Renshaw Global Investment Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Present+at+Rodman+%26amp%3B+Renshaw+Global+Investment+Conference/10865626.html</link>
   <description>si-local-file:///var/storage/newsbody/2015/0903/10865626.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Present+at+Rodman+%26amp%3B+Renshaw+Global+Investment+Conference/10865626.html</guid>
   <pubDate>Thu, 03 Sep 2015 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">20B</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Diagnostics to Present at Rodman &amp;amp; Renshaw Global Investment Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Present+at+Rodman+%26amp%3B+Renshaw+Global+Investment+Conference/10865633.html</link>
   <description>si-local-file:///var/storage/newsbody/2015/0903/10865633.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Present+at+Rodman+%26amp%3B+Renshaw+Global+Investment+Conference/10865633.html</guid>
   <pubDate>Thu, 03 Sep 2015 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
  <item>
   <title>BioMark Diagnostics to Present at Rodman &amp;amp; Renshaw Global Investment Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Present+at+Rodman+%26amp%3B+Renshaw+Global+Investment+Conference/10865633.html</link>
   <description>si-local-file:///var/storage/newsbody/2015/0903/10865633.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioMark+Diagnostics+to+Present+at+Rodman+%26amp%3B+Renshaw+Global+Investment+Conference/10865633.html</guid>
   <pubDate>Thu, 03 Sep 2015 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BMKDF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BUX</category>
   	  </item>
 </channel>
</rss>
